Stress and Inflammation in Late-Life Depression

PHASE4CompletedINTERVENTIONAL

Enrollment

119

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

July 18, 2022

Study Completion Date

July 18, 2022

Conditions

DepressionInflammation

Interventions

DRUG

Escitalopram + Celecoxib

Participants will receive celecoxib in addition to escitalopram

DRUG

Escitalopram + Placebo

Participants will receive a placebo in addition to escitalopram.

Trial Locations (1)

University of Pennsylvania, Philadelphia

All Listed Sponsors

lead

University of Pennsylvania

OTHER

NCT02389465 - Stress and Inflammation in Late-Life Depression | Biotech Hunter | Biotech Hunter